I'm getting out, good luck gents, page-96

Obviously the sp would move up with each offer, but what people have to realise is that we were on the up before the offer, also revenue has been increasing not to mention FDA approval for Sleep Check etc etc.
A return to below 10c is highly unlikely now based on those facts but also that Pfizer desperately wants in, a great recommendation for the company going forward. A CR at around the 8/9c mark to Sophs is my guess, depending on an actual price of 10/11 c after the NO vote.I doubt that there will be time or cash for a spp. of course Pfizer May well put in for a 15% buy in, anyones guess after this week.